These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37966702)

  • 21. Increase in ST-11 serogroup W
    Tsang RS; Hoang L; Tyrrell GJ; Minion J; Van Caeseele P; Kus JV; Lefebvre B; Haldane D; Garceau R; German G; Zahariadis G; Hanley B
    Can Commun Dis Rep; 2019 Jun; 45(6):164-169. PubMed ID: 31285709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of invasive meningococcal disease in Austria 2010.
    Steindl G; Liu YL; Schmid D; Orendi U; Kormann-Klement A; Heuberger S
    Wien Klin Wochenschr; 2011 Oct; 123 Suppl 1():10-4. PubMed ID: 21935643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis.
    Presa JV; de Almeida RS; Spinardi JR; Cane A
    Int J Infect Dis; 2019 Mar; 80():137-146. PubMed ID: 30641200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive Disease Due to
    Stein-Zamir C; Shoob H; Abramson N; Valinsky L; Jaffe J; Maimoun D; Amit S; Davidovich-Cohen M
    Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37764056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive Meningococcal Disease in Africa's Meningitis Belt: More Than Just Meningitis?
    Reese HE; Ronveaux O; Mwenda JM; Bita A; Cohen AL; Novak RT; Fox LM; Soeters HM
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S263-S265. PubMed ID: 31671435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017.
    Nuttens C; Findlow J; Balmer P; Swerdlow DL; Tin Tin Htar M
    Euro Surveill; 2022 Jan; 27(3):. PubMed ID: 35057902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine.
    Ruiz Garcia Y; Abitbol V; Pellegrini M; Bekkat-Berkani R; Soumahoro L
    Infect Dis Ther; 2022 Apr; 11(2):639-655. PubMed ID: 34591258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13.
    Neri A; Pezzotti P; Fazio C; Vacca P; D'Ancona FP; Caporali MG; Stefanelli P
    PLoS One; 2015; 10(10):e0139376. PubMed ID: 26445461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological burden of meningococcal disease in Latin America: A systematic literature review.
    Vespa Presa J; Abalos MG; Sini de Almeida R; Cane A
    Int J Infect Dis; 2019 Aug; 85():37-48. PubMed ID: 31085314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010.
    Dang V; Jamieson FB; Wilson S; Rawte P; Crowcroft NS; Johnson K; Tsang RS; Deeks SL
    BMC Infect Dis; 2012 Aug; 12():202. PubMed ID: 22928839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination.
    Archer BN; Chiu CK; Jayasinghe SH; Richmond PC; McVernon J; Lahra MM; Andrews RM; McIntyre PB;
    Med J Aust; 2017 Nov; 207(9):382-387. PubMed ID: 29092704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines.
    Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L
    Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey.
    Tekin RT; Dinleyici EC; Ceyhan M; Karbuz A; Salman N; Sutçu M; Kurugol Z; Balliel Y; Celik M; Hacimustafaoglu M; Kuyucu N; Kondolot M; Sensoy G; Metin O; Kara SS; Dinleyici M; Kılıç O; Bayhan C; Gurbuz V; Aycan E; Memedova A; Karli A; Bozlu G; Celebi S
    Hum Vaccin Immunother; 2017 May; 13(5):1182-1189. PubMed ID: 28140784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
    Beebeejaun K; Parikh SR; Campbell H; Gray S; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Mar; 80(3):286-290. PubMed ID: 31904388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015-2018.
    Loenenbach AD; van der Ende A; de Melker HE; Sanders EAM; Knol MJ
    Clin Infect Dis; 2020 May; 70(10):2036-2044. PubMed ID: 31556938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic Features of Invasive Meningococcal Disease in Taiwan, 1993 to 2020, and Genetic Characteristics of Neisseria meningitidis Isolates, 2003 to 2020.
    Chiou CS; Liao YS; Chen BH; Lu MC; Hong YP; Wang YW; Teng RH
    Microbiol Spectr; 2022 Aug; 10(4):e0088222. PubMed ID: 35862973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease.
    Scholz S; Schwarz M; Beck E; Meszaros K; Schneider M; Ultsch B; Greiner W
    Infect Dis Ther; 2022 Feb; 11(1):367-387. PubMed ID: 34877641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Australian Meningococcal Surveillance Programme annual report, 2017.
    Lahra MM; Enriquez RP; George CRR
    Commun Dis Intell (2018); 2019 Dec; 43():. PubMed ID: 31838982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013.
    Bröker M; Emonet S; Fazio C; Jacobsson S; Koliou M; Kuusi M; Pace D; Paragi M; Pysik A; Simões MJ; Skoczynska A; Stefanelli P; Toropainen M; Taha MK; Tzanakaki G
    Hum Vaccin Immunother; 2015; 11(9):2281-6. PubMed ID: 26036710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.